Ampio PharmaceuticalsAMPE 13F holders, Q1 2024 (March 31) 28 holders
$0.93 avg. 13F price*
At the end of Q1 2024 , 28 institutions reported holding Ampio Pharmaceuticals Inc. (AMPE) in their 13F filings. The largest holders were Virtu Financial LLC ($18K), Morgan Stanley ($7K) and Tower Research Capital LLC (TRC) ($3K).
Company Ampio Pharmaceuticals Inc.
CUSIP 03209T307
Latest filing quarter Q1 2026 History Number of 13F holders
Total Exit/New Position Q1 2024 Institutions Total Value New Positions 2 $18K Exits 3 $76K
Ownership 28 holders Portfolio Manager % of Holder's Portfolio Change Shares Value ▼ Virtu Financial LLC 0.00% New 19,103 $18K Morgan Stanley 0.00% Add +183.2% 7,809 $7K Tower Research Capital LLC (TRC) 0.00% Add +55.2% 3,537 $3K CVA Family Office, LLC 0.00% No change 3,149 $3K UBS Group AG 0.00% Add +31050.0% 1,246 $1K Cypress Capital Management LLC (WY) 0.00% Reduce -1.3% 461 $424 Osaic Holdings, Inc. 0.00% No change 414 $379 GHP Investment Advisors, Inc. 0.00% No change 300 $276 Sunbelt Securities, Inc. 0.00% No change 206 $190 JPMorgan Chase & Co. 0.00% No change 101 $93 JFS Wealth Advisors, LLC 0.00% No change 83 $77 Janiczek Wealth Management, LLC 0.00% No change 56 $52 Bank of America Corp. 0.00% No change 42 $39 Group One Trading LLC 0.00% No change 35 $32 NFSG Corp 0.00% No change 35 $32 Northwestern Mutual Wealth Management Co. 0.00% No change 26 $24 Farther Finance Advisors, LLC 0.00% No change 18 $14 Sanctuary Wealth Management, L.L.C. 0.00% No change 14 $13 Allworth Financial LP 0.00% No change 10 $10 Arax Advisory Partners 0.00% No change 10 $10 Wells Fargo & Company 0.00% Reduce -84.6% 6 $6 Country Trust Bank 0.00% No change 7 $6 Morton Brown Family Wealth, LLC 0.00% No change 6 $6 Kessler Investment Group, LLC 0.00% New 4 $4 Glen Eagle Advisors, LLC 0.00% No change 4 $4 Mine & Arao Wealth Creation & Management, LLC. 0.00% No change 3 $3 Qube Research & Technologies Ltd 0.00% No change 1 $1 RFP Financial Group LLC 0.00% No change 1 $1
"% of holder's portfolio" is AMPE's weight in each manager's 13F, not the share of Ampio Pharmaceuticals Inc. the manager owns.